TrialOpen forum infectious diseases2026

Sustained Virologic Suppression After Discontinuation of Long-acting Cabotegravir/Rilpivirine: A Two-case Series Highlighting Unexpected Heterogeneity in Pharmacokinetics and Viral Control.

Annalisa Marinosci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.